Skip to main content

COVID-19 Topic Center

FDA News Expert Insights

Pharmacy Learning Network
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means for care access, and how they foresee this new indication…
Pharmacy Learning Network
By Yvette C Terrie, BS Pharm, RPh, Consultant Pharmacist The influenza virus and common cold viruses are typically widespread during this time of year, but this year activity is historically low. According to the CDC, influenza activity for the 2020-2021 influenza season thus far is “remarkably…
Pharmacy Learning Network
By Yvette C Terrie, BS Pharm, RPh, Consultant Pharmacist This year all eyes have been focused on the development and pending approval of a COVID-19 vaccine. In a press release from December 11, 2020, the manufacturers, Pfizer and BioNTech SE announced that the FDA authorized the emergency use of…
Back to Top